CytRx to Present Global Phase 2b Trial of Aldoxorubicin in Soft Tissue Sarcomas Data at ASCO
April 24, 2014 at 07:08 AM EDT
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that ...